Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R T Schapiro

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Physical Medicine and Rehabilitation Clinics of North America|June 17, 1999
Medications used in the treatment of multiple sclerosisR T Schapiro
Current Neurology and Neuroscience Reports|March 20, 2002
Management of spasticity, pain, and paroxysmal phenomena in multiple sclerosisR T Schapiro
Clinical Neuroscience (New York, N.Y.)|January 1, 1994
New advances in symptom management in multiple sclerosisR T Schapiro
Annals of Neurology|January 1, 1994
Symptom management in multiple sclerosisR T Schapiro
Current Opinion in Neurology|June 1, 1994
Symptomatic therapy of multiple sclerosisR T Schapiro, S L Langer
Minnesota Medicine|March 1, 1989
Primary CNS lymphoma presenting as multiple sclerosis. A case studyG P Bender, R T Schapiro
Annals of the New York Academy of Sciences|January 1, 1984
The current management of multiple sclerosisR T Schapiro, S van den Noort, L Scheinberg
Archives of Physical Medicine and Rehabilitation|February 25, 1998
Extended outpatient rehabilitation: its influence on symptom frequency, fatigue, and functional status for persons with progressive multiple sclerosisR P Di Fabio, J Soderberg, T Choi, et al.
Acta Neurologica Scandinavica. Supplementum|January 1, 1984
Field testing of a minimal record of disability in multiple sclerosis: the United States and CanadaN G LaRocca, L C Scheinberg, R J Slater, et al.
Archives of Neurology|June 1, 1997
Relationship of the antispasticity effect of tizanidine to plasma concentration in patients with multiple sclerosisP W Nance, W A Sheremata, S G Lynch, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Physical Medicine and Rehabilitation Clinics of North America|June 17, 1999
Medications used in the treatment of multiple sclerosisR T Schapiro
Current Neurology and Neuroscience Reports|March 20, 2002
Management of spasticity, pain, and paroxysmal phenomena in multiple sclerosisR T Schapiro
Clinical Neuroscience (New York, N.Y.)|January 1, 1994
New advances in symptom management in multiple sclerosisR T Schapiro
Annals of Neurology|January 1, 1994
Symptom management in multiple sclerosisR T Schapiro
Current Opinion in Neurology|June 1, 1994
Symptomatic therapy of multiple sclerosisR T Schapiro, S L Langer
Minnesota Medicine|March 1, 1989
Primary CNS lymphoma presenting as multiple sclerosis. A case studyG P Bender, R T Schapiro
Annals of the New York Academy of Sciences|January 1, 1984
The current management of multiple sclerosisR T Schapiro, S van den Noort, L Scheinberg
Archives of Physical Medicine and Rehabilitation|February 25, 1998
Extended outpatient rehabilitation: its influence on symptom frequency, fatigue, and functional status for persons with progressive multiple sclerosisR P Di Fabio, J Soderberg, T Choi, et al.
Acta Neurologica Scandinavica. Supplementum|January 1, 1984
Field testing of a minimal record of disability in multiple sclerosis: the United States and CanadaN G LaRocca, L C Scheinberg, R J Slater, et al.
Archives of Neurology|June 1, 1997
Relationship of the antispasticity effect of tizanidine to plasma concentration in patients with multiple sclerosisP W Nance, W A Sheremata, S G Lynch, et al.
Pageof 1